Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-07 · accession 0001773751-25-000273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-08-11 | 2025-08-07 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale | $50.58 | -660.0K | 2.21M | -23% | -$33.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-08-07 | S | D | 660,000 | $50.58 | 2,214,769 | I Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 | — | — | (F1) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.25 - $51.125. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |